Status: Recruiting
A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
This study will examine the safety and tolerability of single and multiple doses of IB-001, and will be conducted in two parts: Part A: SAD study in approximately 50 Healthy Volunteers (HV). Part B: MAD study in approximately 30 adult participants living with Chronic Hepatitis B (CHB).
Participants needed: 80
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: IntegerBioUpdated: Jul 2, 2026Locations: 2
Eligibility criteria
Able and willing to provide written informed consent. [+3]
Major surgery requiring general anesthesia within 12 weeks prior to Screening or... [+57]